74
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Adherence to systemic therapies for immune-mediated inflammatory diseases in Lebanon: a physicians’ survey from three medical specialties

, , , , &
Pages 939-945 | Published online: 15 May 2017

References

  • El-GabalawyHGuentherLCBernsteinCNEpidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbiditiesJ Rheumatol Suppl20108521020436161
  • KuekAHazlemanBLOstorAJImmune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolutionPostgrad Med J20078397825126017403952
  • JacobsPBissonnetteRGuentherLCSocioeconomic burden of immune-mediated inflammatory diseases–focusing on work productivity and disabilityJ Rheumatol Suppl201188556122045980
  • SmolenJSAletahaDRheumatoid arthritis therapy reappraisal: strategies, opportunities and challengesNat Rev Rheumatol201511527628925687177
  • World Health OrganizationAdherence to Long-Term Therapies: Evidence for Action2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdfAccessed December 8, 2012
  • KaneSHuoDAikensJHanauerSMedication nonadherence and the outcomes of patients with quiescent ulcerative colitisAm J Med20031141394312543288
  • SoutoAManeiroJRGómez-ReinoJJRate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databasesRheumatology (Oxford)201655352353426490106
  • van StaaTPCardTLoganRFLeufkensHG5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological studyGut200554111573157815994215
  • KaneSVChaoJMulaniPMAdherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patientsAdv Ther2009261093694619838649
  • BhosleMJFeldmanSRCamachoFTTimothy WhitmireJNahataMCBalkrishnanRMedication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasisJ Dermatolog Treat200617529430117092860
  • ZaghloulSSGoodfieldMJObjective assessment of compliance with psoriasis treatmentArch Dermatol2004140440841415096368
  • Pascual-RamosVContreras-YanezIVillaARCabiedesJRull-GabayetMMedication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disabilityArthritis Res Ther2009111R2619228421
  • Contreras-YanezICabiedesJVillaARRull-GabayetMPascual-RamosVPersistence on therapy is a major determinant of patient-, physician- and laboratory-reported outcomes in recent-onset rheumatoid arthritis patientsClin Exp Rheumatol201028574875120863447
  • Contreras-YanezIPonce De LeonSCabiedesJRull-GabayetMPascual-RamosVInadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugsAm J Med Sci2010340428229020881757
  • SaltEFrazierSKAdherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literatureOrthop Nurs201029426027520664466
  • KjekenIDagfinrudHMowinckelPUhligTKvienTKFinsetARheumatology Care: Involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitisArthritis Rheum200655339440116739186
  • BartonJLPatient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapyPatient Prefer Adherence2009333534420016797